EMEA-001034-PIP01-10
Key facts
Invented name |
Risperdal and associated names
|
Active substance |
Risperidone
|
Therapeutic area |
Psychiatry
|
Decision number |
P/167/2011
|
PIP number |
EMEA-001034-PIP01-10
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Treatment of conduct disorder
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Wockhardt UK Ltd
gordon.urquhart@wockhardt.co.uk
United Kingdom Phone: +44 1961773934 |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|